PTC THERAPEUTICS, INC.
NASDAQ: PTCT. Canonical company identity and public leadership record.
US
Record provenance
- Alpha ID
- alpha:company:8ca7a0f6-5501-480b-8f48-1b9871fc788c
- SEC CIK
- 0001070081
- Website
- www.ptcbio.com Open
- Record version
- vpublic-1:ro-d751713988987e9331980363e24189ce, published Nov 12, 2026
- Newest evidence
- Apr 24, 2026
- Monitoring
- Not yet monitored Details
- Integrity
- Not yet signed Methodology
- CEO
- Mark KleinSince Apr 20, 2026
- Chair
- Not published
- Independent
- 1 / 11 directors published
- Published claims
- 223 distinct sources
- Evidence records
- 130 pinned
- Source conflicts
- 0None open
How to read this record
Built from 3 distinct sources and 13 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.
Public record. Alpha publishes governance facts about this organization from regulatory filings and company statements. Private enterprise overlay data is never projected here. The company can claim the record, correct, or dispute any Claim. How this works
CEO ROLE RECORDED
Mark Klein executive of PTC THERAPEUTICS, INC., effective 2026-04-20.
Monitoring
ContinuousWhat the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.
- IdentityunclaimedPublished
- Evidencesource_reportedPublished
- Evaluationnot_evaluatedPublished
- MonitoringNot yet published for this record.Not published
- AuthorityNot yet published for this record.Not published
- FreshnesscurrentPublished
Leadership
Evidence| Role | Person | Since | Status | Claim |
|---|---|---|---|---|
| Chief Executive Officer | Mark Klein | Apr 2026 | current | Source reportedE9 |
| Senior Vice President, Chief Accounting Officer & Head of People Services | Christine Utter | Not captured | unknown | Source reportedE3 |
| Chief Business Officer | Eric Pauwels | Not captured | unknown | Source reportedE4 |
| Vice President of Corporate Communications | Jane Baj | Not captured | unknown | Source reportedE5 |
| Executive Vice President & Chief Medical Officer | Lee Golden | Not captured | unknown | Source reportedE6 |
| Senior VP & Chief Information Officer | Linda Montella Carter | Not captured | unknown | Source reportedE7 |
| Executive VP & Chief Legal Officer | Mark Elliott Boulding | Not captured | unknown | Source reportedE8 |
| CEO & Director | Matthew Klein | Not captured | unknown | Source reportedE10 |
| Chief Technical Operations Officer | Neil Almstead | Not captured | unknown | Source reportedE11 |
| Chief Financial Officer | Pierre Gravier | Not captured | unknown | Source reportedE12 |
Board of directors
Evidence1 directors published. 1 of 1 with a published determination are independent.
| Director | Status | Since | Committees | Claim |
|---|---|---|---|---|
| Jessica Chutter | Independent | 2026 | None published | Source reportedE2 |
| Jerome B. Zeldis | Independent | Not published | Nominating and Governance | Source reportedE2 |
| Mark Klein | Not independent | Not published | None published | Source reportedE2 |
| Stephanie S. Okey | Independent | Not published | Nominating and Governance, chairNominating and Governance · Chair | Source reportedE2 |
Committees and risk ownership
Evidence| Committee | Chair | Members | Risks assigned |
|---|---|---|---|
| Nominating and Governance | Stephanie S. Okey | Stephanie S. Okey, Jerome B. Zeldis | Not described in the published record |
| Nominating and Governance · Chair | Not published | Stephanie S. Okey | Not described in the published record |
Control and voting power
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Authority to act
Evidence and agent registryWho can act for the company, and on whose authority. This is what a counterparty's agent checks before it accepts an order, signs, or pays.
Financials and market context
EvidenceGovernance and policies
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Risk, audit, and cyber
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
AI oversight and accountability
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Legal and regulatory
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Compensation
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Other published claims
EvidencePublished Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.
Not yet in this record
CoverageA gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.
- Corporate structureNot reviewed. Parent, subsidiary and predecessor structure explains who is governed.
- OwnershipNot reviewed. Ownership and voting power determine who can influence the board.
- FinancialsNot reviewed. Governance-relevant financial context frames capital and audit decisions.
- CompensationNot reviewed. Pay design shows how incentives are governed.
- GovernanceNot reviewed. Governing documents and provisions set the rules of the enterprise.
- Shareholder governanceNot reviewed. Meeting and vote records show shareholder dissent and support.
- AuditNot reviewed. Auditor, controls and restatements show assurance over reporting.
- LegalNot reviewed. Material legal and regulatory matters show enforcement exposure.
- RiskNot reviewed. Risk ownership links the board, committees, executives and controls.
- CyberNot reviewed. Cyber and data governance is a disclosed oversight domain.
- AI governanceNot reviewed. AI oversight is a differentiated Alpha governance domain.
- Markets externalNot reviewed. Auditors, advisors, investors and regulators form the external ecosystem.
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.This Company Profile is an identity and evidence record, not an Alpha rating.
Linked people
Same claims as person records- Mark KleinChief Executive Officer; Directorcompany:8ca7a0f6-5501-480b-8f48-1b9871fc788c:leadership_role:17, company:8ca7a0f6-5501-480b-8f48-1b9871fc788c:leadership_role:9
- Christine UtterSenior Vice President, Chief Accounting Officer & Head of People Servicescompany:8ca7a0f6-5501-480b-8f48-1b9871fc788c:leadership_role:11
- Eric PauwelsChief Business Officercompany:8ca7a0f6-5501-480b-8f48-1b9871fc788c:leadership_role:12
- Jane BajVice President of Corporate Communicationscompany:8ca7a0f6-5501-480b-8f48-1b9871fc788c:leadership_role:13
- Lee GoldenExecutive Vice President & Chief Medical Officercompany:8ca7a0f6-5501-480b-8f48-1b9871fc788c:leadership_role:14
- Linda Montella CarterSenior VP & Chief Information Officercompany:8ca7a0f6-5501-480b-8f48-1b9871fc788c:leadership_role:15
- Mark Elliott BouldingExecutive VP & Chief Legal Officercompany:8ca7a0f6-5501-480b-8f48-1b9871fc788c:leadership_role:16
- Matthew KleinCEO & Directorcompany:8ca7a0f6-5501-480b-8f48-1b9871fc788c:leadership_role:18
- Neil AlmsteadChief Technical Operations Officercompany:8ca7a0f6-5501-480b-8f48-1b9871fc788c:leadership_role:19
- Pierre GravierChief Financial Officercompany:8ca7a0f6-5501-480b-8f48-1b9871fc788c:leadership_role:20
- Jessica ChutterDirectorcompany:8ca7a0f6-5501-480b-8f48-1b9871fc788c:leadership_role:8
- Jerome B. ZeldisDirectorcompany:8ca7a0f6-5501-480b-8f48-1b9871fc788c:leadership_role:7
- Stephanie S. OkeyDirectorcompany:8ca7a0f6-5501-480b-8f48-1b9871fc788c:leadership_role:10
Subject and corrections
Public-role doctrineThis record exists because the company is in the published Registry. The company can claim the record, correct, or dispute any Claim. Corrections are versioned and the original stays in history.
- Basis
- Published company record built from public sources
- Sources
- 13 evidence records cited. 0 with redistribution rights.
- Never published
- Private enterprise overlay data: deployments, authority grants, TrustChecks, receipts, telemetry
- Record claimed
- No
- Open disputes
- 0
- Identity ownership
- unclaimed
If the company claims the record, its statements appear as their own assertion state and never overwrite the cited evidence.
Evidence
Authority and rights- E1Alpha canonical company public projection. canonical identity. Retrieved Nov 12, 2026. Cited by 5 Claims.
- E2sec proxy. Published Apr 20, 2026. Retrieved Apr 29, 2026. Cited by 4 Claims.
- E3other. Published Apr 24, 2026. Retrieved Apr 24, 2026. Cited by 1 Claim.
- E4other. Published Apr 24, 2026. Retrieved Apr 24, 2026. Cited by 1 Claim.
- E5other. Published Apr 24, 2026. Retrieved Apr 24, 2026. Cited by 1 Claim.
- E6other. Published Apr 24, 2026. Retrieved Apr 24, 2026. Cited by 1 Claim.
- E7other. Published Apr 24, 2026. Retrieved Apr 24, 2026. Cited by 1 Claim.
- E8other. Published Apr 24, 2026. Retrieved Apr 24, 2026. Cited by 1 Claim.
- E9sec filing. Published Apr 20, 2026. Retrieved May 6, 2026. Cited by 1 Claim.
- E10other. Published Apr 24, 2026. Retrieved Apr 24, 2026. Cited by 1 Claim.
- E11other. Published Apr 24, 2026. Retrieved Apr 24, 2026. Cited by 1 Claim.
- E12other. Published Apr 24, 2026. Retrieved Apr 24, 2026. Cited by 1 Claim.
- E13board_seats. board seats. Cited by 3 Claims.
What changed in version public-1:ro-d751713988987e9331980363e24189ce
vpublic-1:ro-d751713988987e9331980363e24189ce published Nov 12, 2026- Mark Klein executive of PTC THERAPEUTICS, INC., effective 2026-04-20.
- Jessica Chutter seat on PTC THERAPEUTICS, INC., effective 2026-01-01.

